Medios AG | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Medios AG

BRIEF

published on 06/20/2024 at 10:07, 5 months 1 day ago

Successful Transfer of Medios AG Shares to Luxempart S.A.

Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
PRESS RELEASE

published on 06/20/2024 at 10:02, 5 months 1 day ago

Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy

Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF

published on 06/07/2024 at 10:33, 5 months 14 days ago

Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target

Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
PRESS RELEASE

published on 06/07/2024 at 10:28, 5 months 14 days ago

Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies

Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser
BRIEF

published on 06/06/2024 at 11:37, 5 months 15 days ago

Medios AG Completes Acquisition of Ceban, Expanding Market Position in Europe

Acquisition European Market Medios AG Ceban Pharmaceuticals Specialty Pharma
PRESS RELEASE

published on 06/06/2024 at 11:32, 5 months 15 days ago

Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Medios AG completes acquisition of Ceban, expanding market position in Europe. Ceban, a pharmaceutical compounding platform, adds strategic diversification and growth opportunities

Acquisition Medios AG Pharmaceutical Compounding Ceban Pharmaceuticals B.V. European Market Position
BRIEF

published on 05/07/2024 at 07:36, 6 months 14 days ago

Medios AG Reports Revenue Growth in Q1 2024 and Confirms Yearly Targets

Revenue Growth Financial Guidance Medios AG Specialty Pharma Ceban Acquisition
PRESS RELEASE

published on 05/07/2024 at 07:31, 6 months 14 days ago

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance
Medios AG reports 5.8% revenue growth in Q1 2024, reaching €456.2 million. Full-year guidance confirmed, anticipating significant revenue and margin increase. Acquisition of Ceban planned for May 2024

Revenue Growth Medios AG Q1 2024 Full-year Guidance Ceban Acquisition
BRIEF

published on 05/06/2024 at 14:24, 6 months 14 days ago

Medios AG Appoints Constantijn van Rietschoten to Executive Board

Medios AG International Markets Executive Appointment Constantijn Van Rietschoten European Pharma
PRESS RELEASE

published on 05/06/2024 at 14:19, 6 months 14 days ago

Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets
Medios AG appoints Constantijn van Rietschoten as Executive Board member for International Markets, effective May 1, 2024, expanding focus on international growth

Growth Medios AG International Markets Constantijn Van Rietschoten Executive Board Member

Accesswire

Published on 11/21/2024 at 13:30, 38 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 38 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 53 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 33 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 53 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours 2 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 8 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 10 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 48 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE